cariprazine and Mood-Disorders

cariprazine has been researched along with Mood-Disorders* in 1 studies

Reviews

1 review(s) available for cariprazine and Mood-Disorders

Article	Year
[The dopamin D3 receptor--the gray eminence of pharmacotherapy?]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2010, Volume: 12, Issue:3 The dopamine system plays a crucial role in the pathophysiology of many neuropsychiatric disorders. Altough there is sufficient information and knowledge about several dopamine receptor subtypes and their functions, until the last decade the role of the D3 receptor was almost unclear. Recent research data proved that the D3 receptor might have a significant role in fine tuning the modulation of dopaminergic neurotransmission. Cariprazine is a novel agent developed in Hungary, its activity on the dopamine D3 receptor might open up new dimensions in the pharmacotherapy of schizophrenia and affective disorders. Topics: Animals; Antipsychotic Agents; Humans; Hungary; Mood Disorders; Piperazines; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Synaptic Transmission	2010

Article

Year

[The dopamin D3 receptor--the gray eminence of pharmacotherapy?].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2010, Volume: 12, Issue:3

The dopamine system plays a crucial role in the pathophysiology of many neuropsychiatric disorders. Altough there is sufficient information and knowledge about several dopamine receptor subtypes and their functions, until the last decade the role of the D3 receptor was almost unclear. Recent research data proved that the D3 receptor might have a significant role in fine tuning the modulation of dopaminergic neurotransmission. Cariprazine is a novel agent developed in Hungary, its activity on the dopamine D3 receptor might open up new dimensions in the pharmacotherapy of schizophrenia and affective disorders.

Topics: Animals; Antipsychotic Agents; Humans; Hungary; Mood Disorders; Piperazines; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Synaptic Transmission

2010